Modular Medical Growth Metrics (2009-2014) | MODD

Growth Metrics Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Dec2013 Mar2014
Growth Ratios
Capital Expenditures Growth (1y) 200.00%0.00%0.00%0.00%
Capital Expenditures (QoQ) 200.00%0.00%0.00%0.00%
Cash from Investing Activities Growth (1y) 0.00%0.00%0.00%0.00%
Cash from Investing Activities (QoQ) 0.00%0.00%0.00%0.00%
Cash from Operations Growth (1y) -1.74%0.00%0.00%0.00%
Cash from Operations (QoQ) -1.74%0.00%0.00%0.00%
EBIT Growth (1y) -42.50%-20,712.70%-13.60%-55.51%0.58%98.29%-9.68%-24.44%-16.94%-7,921.49%-9.52%-12.56%-3.12%
EBIT Growth (3y) -18.33%-558.52%-10.92%-29.63%-6.23%
EBIT (QoQ) 52.08%-499.65%71.84%-76.11%-6,898.42%96.73%61.45%-12.58%-20.41%-109.87%56.26%-5.80%-8,159.56%97.13%55.05%3.07%
EBT Growth (1y) -42.50%-24,020.87%5.32%-55.51%0.58%98.52%-56.62%-154.37%-131.82%-8,311.28%-13.95%-18.33%-15.61%
EBT Growth (3y) -48.64%-569.02%-19.11%-67.28%-38.63%
EBT (QoQ) 52.08%-619.48%76.53%-76.11%-8,010.82%97.18%61.45%-12.58%-20.41%-199.71%37.39%-2.60%-4,268.92%95.94%34.99%-0.24%
EPS (Basic) Growth (1y) -42.50%-24,020.87%100.00%99.82%99.99%100.00%0.00%0.00%0.00%-8,311.28%44.06%63.63%63.55%
EPS (Basic) Growth (3y) 95.63%86.62%97.62%91.40%97.23%
EPS (Basic) (QoQ) 52.08%-619.48%98.62%-2,893.82%-8,010.82%100.00%0.00%0.00%83.62%-510.56%0.00%0.00%-1,277.63%95.94%34.99%-0.24%
EPS (Weighted Average and Diluted) Growth (1y) -42.50%-24,020.87%5.32%-55.51%0.58%-154.37%
EPS (Weighted Average and Diluted) (QoQ) 52.08%-619.48%76.53%-76.11%-8,010.82%97.18%61.45%-12.58%
Free Cash Flow Growth (1y) -57.60%0.00%0.00%0.00%
Free Cash Flow (QoQ) -57.60%0.00%0.00%0.00%
Interest Coverage Ratio Growth (1y) 11.89%9.12%19.64%
Interest Coverage Ratio (QoQ) 59.00%-6.29%-1,921.67%90.00%57.71%6.01%
Net Income Growth (1y) -42.50%-24,020.87%5.32%-55.51%0.58%98.52%-56.62%-154.37%-131.82%-8,311.28%-13.95%-18.33%-15.61%
Net Income Growth (3y) -48.64%-569.02%-19.11%-67.28%-38.63%
Net Income (QoQ) 52.08%-619.48%76.53%-76.11%-8,010.82%97.18%61.45%-12.58%-20.41%-199.71%37.39%-2.60%-4,268.92%95.94%34.99%-0.24%
Net Income towards Common Stockholders Growth (1y) -42.50%-24,020.87%5.32%-55.51%0.58%98.52%-56.62%-154.37%-131.82%-8,311.28%-13.95%-18.33%-15.61%
Net Income towards Common Stockholders Growth (3y) -48.64%-569.02%-19.11%-67.28%-38.63%
Net Income towards Common Stockholders (QoQ) 52.08%-619.48%76.53%-76.11%-8,010.82%97.18%61.45%-12.58%-20.41%-199.71%37.39%-2.60%-4,268.92%95.94%34.99%-0.24%
Operating Income Growth (1y) -42.50%-13.60%-55.51%0.58%98.29%-9.68%-24.44%-16.94%-7,921.49%-9.52%-12.56%-3.12%
Operating Income Growth (3y) -18.33%-10.92%-29.63%-6.23%
Operating Income (QoQ) 71.84%-76.11%-6,898.42%96.73%61.45%-12.58%-20.41%-109.87%56.26%-5.80%-8,159.56%97.13%55.05%3.07%
Profit After Tax Growth (1y) 242.50%-20.52%3,712.04%-55.51%-199.42%-114.13%-104.11%-154.37%-131.82%-8,311.28%-13.95%-18.33%-15.61%
Profit After Tax Growth (3y) -48.64%-125.37%-19.11%-67.28%-67.08%
Profit After Tax (QoQ) 1,618.75%-122.70%76.53%276.11%747.13%931.55%-101.01%-12.58%-20.41%-199.71%37.39%-2.60%-4,268.92%95.94%34.99%-0.24%
Return on Equity Growth (1y) 189.00175.00165.00
Return on Equity (QoQ) 2.002.00196.00-12.00-11.00-8.00
Return on Sales (QoQ) -1058.00-50.00-44.00
Share-based Compensation Growth (1y) 0.00%0.00%
Share-based Compensation (QoQ) 0.00%0.00%0.00%
Shareholder's Equity Growth (1y) -24.77%-23.91%-23.64%-23.27%
Shareholder's Equity (QoQ) -8.69%-5.00%-4.89%-4.23%-7.94%-4.78%-4.57%
Total Debt Growth (1y) 13.90%14.26%7.15%13.57%13.17%13.99%14.84%14.89%14.41%13.23%12.97%
Total Debt Growth (3y) 13.98%14.22%13.39%13.88%13.67%
Total Debt (QoQ) 1.08%7.38%1.98%2.90%1.40%0.70%8.08%2.54%2.14%2.59%1.71%5.06%3.28%2.36%